Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma

NCT00209079 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class

Stopped Terminated 4/17/07. Drug sponsor withdrew.

Conditions

Interventions

Sponsor

Emory University

Collaborators